Demetrios George Stavrakis

Demetrios Stavrakis practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Demetrios Stavrakis' NPI, 1780118968, was assigned on April 14, 2017. Demetrios Stavrakis graduated from UC Irvine School of Medicine in 2017. Demetrios Stavrakis holds California license A185747.

Demetrios Stavrakis' primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Demetrios Stavrakis' primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Demetrios Stavrakis is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Demetrios Stavrakis to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Demetrios Stavrakis practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Demetrios Stavrakis' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Demetrios Stavrakis is board certified in gastroenterology by the American Board of Internal Medicine. Demetrios Stavrakis is licensed in California.

Dmand AI lists acid reflux, gastroduodenitis and irritable bowel syndrome (IBS) among the conditions Demetrios Stavrakis treats.

CMS data shows 653 Medicare services from Demetrios Stavrakis across 10 procedure codes in 2024, for 384 Medicare patients. Medicare paid $79,022 for them.

CMS counts 384 Medicare patients who saw Demetrios Stavrakis in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Demetrios Stavrakis' median patient age at 59, with 52% women.

In 2024, Demetrios Stavrakis wrote 636 Medicare Part D claims for 278 patients. 83% of them were for generic drugs. CMS names the drug for 550 of them, across 11 drugs with 11 or more claims each, at $56,483 in total drug cost. In 2023, CMS named 82 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Demetrios Stavrakis for performance year 2024, reported as part of a group. Demetrios Stavrakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Demetrios Stavrakis as offering telehealth. CMS counts 108 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Demetrios Stavrakis, more than 78% of the clinicians it reports for that procedure.

CMS Open Payments shows 6 general payments to Demetrios Stavrakis from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $182.

Demetrios Stavrakis graduated from UC Irvine School of Medicine in 2017.

Demetrios Stavrakis is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.